Product Images Alendronate Sodium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Alendronate Sodium NDC 53217-321 by Aidarex Pharmaceuticals Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

arrow - alendronate sodium usp 35mg tablet 1

arrow - alendronate sodium  usp 35mg tablet 1

arrow - alendronate sodium usp 35mg tablet 10

arrow - alendronate sodium  usp 35mg tablet 10

Alendronate Sodium, USP tablet - alendronate sodium usp 35mg tablet 11

Alendronate Sodium, USP tablet - alendronate sodium  usp 35mg tablet 11

arrow - alendronate sodium usp 35mg tablet 2

arrow - alendronate sodium  usp 35mg tablet 2

Structural formula for Alendronate Sodium - alendronate sodium usp 35mg tablet 3

Structural formula for Alendronate Sodium - alendronate sodium  usp 35mg tablet 3

Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT (patients with radiographic vertebral fracture at baseline) - alendronate sodium usp 35mg tablet 4

Cumulative Incidence of Hip Fractures in the Three-Year Study of FIT (patients with radiographic vertebral fracture at baseline) - alendronate sodium  usp 35mg tablet 4

Osteoporosis Treatment Studies in Postmenopausal Women Increase in BMD Alendronate Sodium 10 mg/day at Three Years - alendronate sodium usp 35mg tablet 5

Osteoporosis Treatment Studies in Postmenopausal Women Increase in BMD Alendronate Sodium 10 mg/day at Three Years - alendronate sodium  usp 35mg tablet 5

Osteoporosis Treatment Studies in Postmenopausal Women Time Course of Effect of Alendronate Sodium 10 mg/day Versus Placebo: Lumbar Spine BMD Percent Change From Baseline - alendronate sodium usp 35mg tablet 6

Osteoporosis Treatment Studies in Postmenopausal Women Time Course of Effect of Alendronate Sodium 10 mg/day Versus Placebo: Lumbar Spine BMD Percent Change From Baseline - alendronate sodium  usp 35mg tablet 6

Osteoporosis Prevention Studies in Postmenopausal Women - alendronate sodium usp 35mg tablet 7

Osteoporosis Prevention Studies in Postmenopausal Women - alendronate sodium  usp 35mg tablet 7

Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year - alendronate sodium usp 35mg tablet 8

Studies in Glucocorticoid - Treated Patients Increase in BMD Alendronate Sodium 5 mg/day at One Year - alendronate sodium  usp 35mg tablet 8

Studies in Paget’s Disease of Bone Effect on Serum Alkaline Phosphatase of Alendronate Sodium 40 mg/day Versus Placebo or Etidronate 400 mg/day - alendronate sodium usp 35mg tablet 9

Studies in Paget’s Disease of Bone Effect on Serum Alkaline Phosphatase of Alendronate Sodium 40 mg/day Versus Placebo or Etidronate 400 mg/day - alendronate sodium  usp 35mg tablet 9